Her-2 NEGATIVE = 162

Her-2 POSITIVE = 37

Recalled

59 (36.4%)

11 (29.7%)

Further ipsilateral malignancy

22 (13.5%)

6 (16.2%)

(OR 0.83, 95% CI 0.3 - 2.2)

Contralateral malignancy

2 (1.2%)

0

B3/B4

5 (3.08%)

1 (2.7%)

MRI/PATH SIZE CONCORDANCE

(WITHIN 10 MM)

114 (70.3%) (p value > 0.1)

18 (48.6%) (p value > 0.2)

MRI/PATH SIZE DISCORDANCE

(>10 MM DISCORDANCE)

48 (29.6%)

19 (51.3%)

MRI > PATH SIZE

(10 MM OR MORE DIFFERENCE)

34/48

(70.8% OF DISCORDANCE)

17/19

(89.4% OF DISCORDANCE)